Pathogen Genomics Center, National Institute of Infectious Diseases, Shinjuku-ku, Tokyo NTT Medical Center Tokyo, Shinagawa-ku, Tokyo, Japan.
Cancer Sci. 2011 Jun;102(6):1223-7. doi: 10.1111/j.1349-7006.2011.01922.x. Epub 2011 Mar 30.
Genotyping human papillomavirus (HPV) in clinical specimens is important because each HPV type has different oncogenic potential. Amplification of HPV DNA by PCR with the consensus primers that are derived from the consensus sequences of the L1 gene has been used widely for the genotyping. As recent studies have shown that the cervical specimens often contain HPV of multiple types, it is necessary to confirm whether the PCR with the consensus primers amplifies multiple types of HPV DNA without bias. We amplified HPV DNA in the test samples by PCR with three commonly used consensus primer pairs (L1C1/L1C2+C2M, MY09/11, and GP5+/6+), and the resultant amplicons were identified by hybridization with type-specific probes on a nylon membrane. L1C1/L1C2+C2M showed a higher sensitivity than the other primers, as defined by the ability to detect HPV DNA, on test samples containing serially diluted one of HPV16, 18, 51, 52, and 58 plasmids. L1C1/L1C2+C2M failed to amplify HPV16 in the mixed test samples containing HPV16, and either 18 or 51. The three consensus primers frequently caused incorrect genotyping in the selected clinical specimens containing HPV16 and one or two of HPV18, 31, 51, 52, and 58. The data indicate that PCR with consensus primers is not suitable for genotyping HPV in specimens containing multiple HPV types, and suggest that the genotyping data obtained by such a method should be carefully interpreted.
对临床标本进行人乳头瘤病毒(HPV)基因分型非常重要,因为每种 HPV 类型都具有不同的致癌潜能。通过使用源自 L1 基因的保守序列的通用引物进行聚合酶链反应(PCR)扩增 HPV DNA,已广泛用于基因分型。由于最近的研究表明宫颈标本通常含有多种 HPV 类型,因此有必要确认通用引物的 PCR 是否存在偏倚地扩增多种 HPV DNA 类型。我们使用三种常用的通用引物对(L1C1/L1C2+C2M、MY09/11 和 GP5+/6+)通过 PCR 扩增测试样本中的 HPV DNA,并将所得扩增子与尼龙膜上的型特异性探针杂交进行鉴定。L1C1/L1C2+C2M 比其他引物具有更高的灵敏度,因为它能够检测到包含 HPV16、18、51、52 和 58 质粒的连续稀释的测试样本中的 HPV DNA。L1C1/L1C2+C2M 在包含 HPV16 以及 HPV18 或 51 的混合测试样本中未能扩增 HPV16。三种通用引物在包含 HPV16 和 HPV18、31、51、52 和 58 中的一种或两种的选定临床标本中经常导致错误的基因分型。这些数据表明,包含通用引物的 PCR 不适合对包含多种 HPV 类型的标本进行 HPV 基因分型,并提示应仔细解释通过这种方法获得的基因分型数据。